Personalized Medicine meetings & conferences

International Federation for Information Processing/International Medical Informatics Association International Working Conference on Interfacing Bio- and Medical Informatics

27 September 2012 Amsterdam, the Netherlands

From 24 to 26 September 2012 the International Federation for Information Processing (IFIP) is having its World Computer Congress WCC2012 in Amsterdam, the Netherlands (www.wcc-2012.org). During the WCC2010 conference in Brisbane, Australia, IFIP and the International Medical Informatics Association (IMIA) organized a joint conference for the first time in their history. Also this time a joint one-day associated meeting will be held on Thursday 27 September. The topic of this meeting will be the link between bioinformatics and medical informatics. IFIP’s Working Groups 5.13 Bioinformatics and its applications and IMIA’s Working Group on Informatics in Genomic Medicine (IGM) are working in this area and supporting this event.

Contact
Prof.dr. Arie Hasman e-mail: a.hasman@amc.uva.nl

Conference topics

Applications:

Personalized medicine

Cancer informatics

Population genetics

Bioinformatics approaches for diseases study

Genomics and proteomics in medicine

Analysis of gene expression, mutation, variations and next generation sequencing

Linking genotype with phenotype

Tools:

Databases, data management and integration

Query languages, information retrieval, interoperability, biomedical ontologies and semantics

Knowledge discovery, machine learning, pattern recognition and text mining

Data visualization

High-performance, grid and cloud computing

American Society of Human Genetics 62nd Annual Meeting

Tuesday, November 6 through Saturday, November 10, 2012 San Francisco, California

The world's top scientists and clinicians in the human genetics field will gather to present their latest research findings at the 62nd Annual Meeting of the American Society of Human Genetics (ASHG), which will be held on November 6-10, 2012, in San Francisco, CA (http://www.ashg.org/2012meeting). ASHG is the primary professional membership organization for human genetics specialists worldwide, representing nearly 8,000 researchers, academicians, clinicians, genetic counselors, nurses, and others with a special interest in this area (http://www.ashg.org).

The ASHG Annual Meeting continues to be the largest human genetics meeting in the world, attracting more than 7,000 scientific participants each year. The ASHG 2012 Meeting will provide attendees with the latest information about cutting-edge developments in human genetics and genomics research. In addition, nearly 250 U.S. and international exhibitors at this year's ASHG Exhibitor Trade Show will offer an unprecedented opportunity to view the latest advances in genetics-related products and services derived, in part, from work presented at previous ASHG meetings.

Topics to be addressed in the scientific program for the ASHG 2012 Meeting will include: gene discovery in human genetics; new insights and challenges from next generation sequencing; advances in medical genetics and translation/applications in clinical care; progress in gene therapy; personalized medicine; cancer genetics; advances in non-invasive prenatal diagnosis; revelations about human alleles from studies of model organisms; implications of population genetic studies; modeling in statistical genetics; data centralization and its implications for our field; ethical, legal and social implications of genomics; changes in genetics education; and much more.

For more information about the ASHG 2012 Annual Meeting, or to register and/or submit an abstract for presentation at this year’s meeting, please go to: http://www.ashg.org/2012meeting.

Cambridge Healthtech Institute Inaugural Innovative Tissue-Based Diagnostics Conference

June 4-5, 2012 Philadelphia, Pennsylvania

Innovative Tissue-Based Diagnostics is designed to feature recent breakthroughs in the field of pathology such as testing for predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. The goal of the conference is to enhance knowledge and experience exchange among industry and research pathologists as well as other researchers working with human tissue. This meeting will highlight the new generation of tissue-based diagnostic technologies aimed primarily towards molecular diagnostics of cancer. In addition, a session dedicated to the fascinating field of in vivo pathology will be offered.

KEY TAKE AWAYS:
• Learn about pathology's contribution and role in cancer drug development
• Get updates on how cancer pathology helps create genetically informed cancer medicine
• Learn how next generation sequencing has revolutionized genomics and is now on the verge of being widely adopted for medical sequencing
• Hear insights into in vivo microscopy and intra-operative optical imaging – a fascinating new and rapidly developing field of diagnostic medicine
• Get instructed on the challenges and solutions in assay development for the clinical setting

SESSIONS:

• Pathology in Cancer Drug Development
• Molecular Pathology as the Driving Force for Personalized Oncology
• Bridging Radiology-Pathology Divide

PRE-CONFERENCE SHORT COURSE - June 4 (9:00 am - 12:00 pm) Next-Generation Sequencing as a Diagnostics Platform

Cambridge Healthtech Institute:
250 First Avenue
Suite 300
Needham, MA 02494
Phone: 781-972-5400
Toll-Free: 888-999-6288
Fax: 781-972-5425
Web: www.chicorporate.com

2012 International Society for Quality of Life Research Annual Conference

The Journey of Quality of Life Research: A Path Towards Personalized Medicine

The 2012 ISOQOL 19th Annual Conference will be held in Budapest, Hungary, 24-27 October.

Our goal is to provide attendees with a conference focused on the most important topics and trends in health-related quality of life research through thought-provoking, relevant presentations.

Mathematical and Computational Medicine Conference 2012

Saturday December 1 2012 - Wednesday December 5 2012 Xcaret, Mexico

The purpose of the Zing Conference on Mathematical and Computational Medicine is to bring together eminent scholars with expertise in various fields of mathematical and computational medicine, as well as experimentalists and medical doctors interested in application of computational methods in clinical studies. The mathematical and computational medicine is now one of the most important and rapidly growing fields of modern medicine, and will become even more important in nearest future, when the cost of individual human gene sequencing becomes affordable for mass-scale clinical use (The $1000 Human Genome). New sequencing techniques, such as RNA-Seq produce enormous amount of information on the transcriptome in healthy and diseased cells, that need a development of new mathematical and computational methods to extract the most important medical information. The scope of the proposed Zing Conference will cover many different fields mathematical and computational medicine and biomedical informatics, such as genetics, genomics, epigenetics, and epigenomics of various diseases including mental and learning disorders, autism, and somatic diseases, with a special emphasis on cancer, protein misfolding disorders related to amyloid formation in neurogenerative diseases (such as Alzheimer's and Parkinson's disease), gene regulation, biomarker development, computer aided drug development, computational pharmacodynamics, computational immunology, systems biology and its extension to systems medicine, machine learning methods in application to biomedical data, applicability of computational methods in personalized medicine, and regenerative medicine. A special session will be devoted to errors in measurements of biomedical data and statistical evidence-based medicine.

For general queries about conference attendance, registration, payment, accommodation, etc. please email info~at~zingconferences.com (replace '~at~' with '@').

Why We Can’t Wait: Conference to Eliminate Health Disparities in Genomic Medicine

May 31 - June 1, 2012 Miami, Florida

Genetic advances hold extreme promise, but also the potential to further increase health disparities. Now is the time to address this. Join a forum of stakeholders to learn, identify, and discuss many of the challenges and possible solutions for addressing health disparities in genomic medicine.

Who should attend:

Physicians, researchers, ethicists, allied health professionals (i.e., nurses, psychologists, etc.), public health specialists, and members of the community.

Conference goals and objectives:

Educational Goals
o Understand the role genomics plays in health disparities
o Understand the impact of genomic medicine disparities on current disease management
o Appreciate the role genetic research could play in remedying health disparities.
o Anticipate future challenges in integrating genomic medicine in all populations
o Create a forum for stakeholders to identify and generate plausible solutions for health disparities in genomic medicine

Overall Learning Objectives
Specific talks will accomplish these from varying ethnic and disease perspectives.
o Define the role of genomic medicine in healthcare
o Identify current disparities in healthcare related to genetics and genomic medicine
o Predict the disparities that may emerge with the integration of genomic medicine, including sequencing
o Recognize the importance of genomic research and minority participation in such research
o Cite the gaps in translation due to lack of participation in genomic medicine research
o Analyze and implement methods to overcome barriers to research participation in their community
o Anticipate the resources needed to appropriately integrate genomic medicine into clinical practice so that all persons benefit.

For more information or to register, please visit: http://geneticsawareness.org/2012conference

To contact the Planning Committee, please email: HIHGGAPCONF@med.miami.edu

4th Annual Personalized Medicine Conference

September 12-13, 2012 Boston, Massachusetts

Personalized medicine has the potential to revolutionize medical care by utilizing an improved understanding of genetics and molecular biology to allow for better diagnostic tests, more precise diagnoses, greater predictability of disease course, and improved patient safety by selecting not only the right drug for a patient but also the proper dosage to reduce adverse effects. Speakers and panelists will answer the following key questions:

What types of challenges need to be met in order to realize the true commercial potential of personalized medicine?
Will insurers fund the genomic revolution?
What types of validation requirements are they looking for?
What will be their criteria for reimbursement?
What are the real-world challenges to successful adoption of molecular/companion diagnostics?
Who needs to partner in order to advance the field of personalized medicine?
What are the goals, utility and challenges associated with Rx-Dx partnerships?
How and when are relationships being initiated today?
How are companies navigating their way through the world's regulatory bodies?
What kind of impact are Pharmacy Benefit Managers (PBMs) and for that matter new genetic testing benefit managers going to have on the future of personalized medicine?
What types of efforts are being made to influence adoption via physician education?

Arrowhead Publishers and Conferences
5412 Irving Avenue South
Minneapolis
MN
55419
USA

E-mail: enquiries@personalizedmedicinepartnerships.com
Telephone: 312-244-3703
Fax: 312-244-3703
http://www.arrowheadpublishers.com

Worldwide Innovative Networking (WIN) Consortium WIN 2012 Symposium

The Worldwide Innovative Networking (WIN) Consortium invites you to attend the WIN 2012 Symposium, to be held in Paris, June 28-29, 2012. This symposium will be the next in the successful series of annual meetings dedicated to personalized cancer medicine. The WIN Consortium was created to accelerate the pace and reduce the cost of translating effective cancer treatments to the bedside. The WIN 2012 Symposium provides an open forum for discussion between all stakeholders in cancer biomarkers and therapeutics development and great networking opportunities for everyone involved in improving cancer patient care at the level of the individual patient.

The main theme of the 2012 symposium, Efficacy of biomarkers and personalized cancer therapeutics, will be elaborated in various plenary sessions, bringing together a unique assembly of high-ranking experts from academia, industry and regulatory agencies wordwide as speakers and moderators. The Best Poster Award Session will provide an opportunity for oral presentation of the best abstract/poster in each of the following categories: diagnostics, therapeutics, technologies and tools development, and computational / bioinformatics.

For matters regarding the 4th WIN Symposium, please contact the Symposium Secretariat directly:

Congress by design
P.O. Box 77
3480 DB Harmelen
The Netherlands

Tel. +31 88 089 8101
Fax +31 88 089 8109

Email: win@congressbydesign.com

www.congressbydesign.com

ITBAM '12 3rd International Conference on Information Technology in Bio- and Medical Informatics

Vienna (Austria) September 3 - 7, 2012

Data intensive disciplines, such as life sciences and medicine, are promoting vivid research activities in the area of databases. Modern technologies, such as high-throughput mass-spectrometry and sequencing, micro-arrays, high-resolution imaging, etc. produce enormous and continuously increasing amounts of data. Huge public databases provide access to aggregated and consolidated information on genome and protein sequences, biological pathways, diseases, anatomy atlases, and scientific literature. There has never been more potentially available information to study biomedical systems, ranging from single cells to complete organisms. However, it is a non-trivial task to transform the vast amount of biomedical data into actionable information triggering scientific progress and supporting patient management. Major biomedical application scenarios for research in the database community include but are not limited to:

Systems biology
Genomics, proteomics, and metabolomics
Genome-wide association studies
Drug target discovery and personalized medicine
Neuroscience and neuroinformatics
Electronic patient records
Patient monitoring
Surgery planning and support
etc.

Various emerging database technologies for coping with the challenges of these application scenarios have been developed and are an active area of research in information technology:
Administration of vast amounts of data
Integration of heterogeneous data sources
Federated and distributed databases
Data warehouses
Data mining techniques such as classification, clustering, association rule mining, etc.
Decision support systems
Information and image retrieval
Signal processing and streaming databases
Privacy protection and data security
Data quality assurance
Process management and collaborative work
User interfaces and visualization
Interoperability and standardization
etc.

Designing database technology to support applications in life sciences and medicine is an inspiring field of interdisciplinary research. The path from an idea to a practical application is often long and laborious, involving intensive interactions between experts in information technology, life sciences and the medical field. ITBAM accompanies and supports this path by providing an excellent venue for the exchange of ideas, fruitful discussion, and effective interaction among interdisciplinary researchers.

9th International Conference on Wearable Micro and Nano Technologies for Personalized Health (pHealth)

June 26-28, 2012 Porto, Portugal

The pHealth conference has emerged as the leading international meeting on wearable micro and nano technologies for personalized medicine. Starting in 2004, pHealth has attracted scientists for various technologies, medical doctors, policy makers from the healthcare industry, hospital administration and allied professionals.

Collecting a dynamic professional community from Europe and all over the world pHealth has given visibility to the tremendous potential of micro and nano technologies not only for the future of medicine, but also for the improvement of healthcare processes today.

Microsystems, smart textiles, telemedicine, smart implants and sensor-controlled medical devices have become important enablers for monitoring and treatment in both inpatient and outpatient care. This is, however, just the beginning of revolutionary changes and significant opportunities are given for patients, companies and the healthcare industry.

The multilateral benefits of pHealth technologies for all three stake-holders lead to a triple win situation with enormous potential, not only for medical quality improvement and industrial competitiveness, but also for managing healthcare cost.